Skip to content
EOLO PHARMA logo — Cutting-Edge Pharmacological Treatment for Obesity

EOLO PHARMA

Cutting-Edge Pharmacological Treatment for Obesity

Founded 2017 United States San Francisco, United States 12 employees Venture round Total: $4.50M Biopharma, Biotechnology +2

General Information

Company Name EOLO PHARMA
Founded Year 2017
Location United States San Francisco, United States
Employees 12
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with EOLO PHARMA. To contact EOLO PHARMA, visit eolo-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EOLO PHARMA compare?

A PDF of EOLO PHARMA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EOLO PHARMA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EOLO PHARMA

EOLO PHARMA is a biotechnology company founded in 2017. The company is focused on drug discovery, specifically on developing novel molecules for the treatment of obesity. Operating within the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, EOLO PHARMA is headquartered in the United States. The most recent milestone for EOLO PHARMA is the $1.80M Venture Round investment it secured on February 8, 2023. This financial backing will undoubtedly contribute to the company's ongoing research and development efforts, as well as its overall growth trajectory. As a biotechnology company specializing in obesity treatment, EOLO PHARMA occupies a significant position within the healthcare and biopharmaceutical sectors. This recent investment is a testament to the continued potential and promise that the industry sees in EOLO PHARMA's innovative approach to drug discovery.

Business keywords: Drug Discovery, Obesity Treatment, Chronic Inflammation, Pharmaceuticals, Molecular Drugs, Inflammation-related Diseases, Small Molecules, Research and Development, Molecular Basis, Cellular Basis, Drug Development, Biomedical Technology, Therapeutic Molecules, Biomedical Research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.80M -
08 Feb 2023
Series A $2.70M 2
Ficus Capital, Cites
07 Jan 2020

EOLO PHARMA Alternatives & Competitors

View All Alternatives
EOLO PHARMA vs

Danish biotech company developing peptide-small molecule drugs for treatment of obesity

Convertible Note
6 employees
Biotechnology, Pharmaceutical
EOLO PHARMA vs
Orbit Discovery
Orbit Discovery United Kingdom

Delivering Peptide Enabled Drug Discovery Solutions

Seed
31 employees
Biotechnology, Health Care
EOLO PHARMA vs

Pioneering the future of metabolic disease treatment by harnessing genetic interactions to combat ag...

Series D
Biotechnology, Pharmaceutical

FAQ About EOLO PHARMA

Cutting-Edge Pharmacological Treatment for Obesity
EOLO PHARMA was founded in 2017.
EOLO PHARMA is headquartered in San Francisco, United States.
EOLO PHARMA operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Drug Discovery, Obesity Treatment, Chronic Inflammation and Pharmaceuticals.
EOLO PHARMA has approximately 12 employees.
EOLO PHARMA has completed 2 funding rounds, raising a total of $4.50M. The latest funding stage is Venture round.
Top alternatives and competitors to EOLO PHARMA include Ousia Pharma, Orbit Discovery, Elixir Pharmaceuticals, Ambrosia Biosciences Inc., Advenchen Laboratories, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EOLO PHARMA and Ousia Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EOLO PHARMA, https://bouncewatch.com/company/eolo-pharma, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout